1 of infancy (NEHI) and pulmonary interstitial glycogenosis.

2 -of-function mutation in GYS1 resulting in a glycogenosis.

3 namide alcohol aversion therapy, and type IV glycogenosis.

4 accharide storage myopathy (PSSM) is a novel glycogenosis in horses characterized by abnormal glycoge

5 ase 1 deficiency, previously identified as a glycogenosis, is also a congenital disorder of glycosyla

6 plasia of infancy and pulmonary interstitial glycogenosis, present early in life with characteristic

7  stimulating factor (G-CSF) in patients with glycogenosis-related pancytopenia might ameliorate the I

8            McArdle disease is a nonlysosomal glycogenosis that classically manifests with exercise-in

9                                              Glycogenosis type II is a recessively inherited disorder

10 ively inherited myopathy and cardiomyopathy, glycogenosis type II.

11      Deficiency of muscle isoenzyme (PFK-M), glycogenosis type VII (Tarui disease), is an autosomal r

12 up of disorders is the defect of aldolase A (glycogenosis type XII), a block in terminal glycolysis a

13 l variants, including a brief description of glycogenosis type XII; animal models, both spontaneous a